CRP and inflammatory bowel disease: Leucine-rich alpha- 2 glycoprotein (LRG) is a novel serum marker for inflammatory bowel disease (IBD) and has been recently reported to be more accurate than CRP as a marker of endoscopic severity and might be equivalent to Fcal [13–16].